GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hainan Shuangcheng Pharmaceuticals Co Ltd (SZSE:002693) » Definitions » Additional Paid-In Capital

Hainan Shuangcheng Pharmaceuticals Co (SZSE:002693) Additional Paid-In Capital : ¥0.0 Mil(As of Mar. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Hainan Shuangcheng Pharmaceuticals Co Additional Paid-In Capital?


Hainan Shuangcheng Pharmaceuticals Co's quarterly additional paid-in capital increased from Sep. 2023 (¥0.0 Mil) to Dec. 2023 (¥319.4 Mil) but then stayed the same from Dec. 2023 (¥319.4 Mil) to Mar. 2024 (¥0.0 Mil).

Hainan Shuangcheng Pharmaceuticals Co's annual additional paid-in capital increased from Dec. 2021 (¥292.9 Mil) to Dec. 2022 (¥307.9 Mil) and increased from Dec. 2022 (¥307.9 Mil) to Dec. 2023 (¥319.4 Mil).


Hainan Shuangcheng Pharmaceuticals Co Additional Paid-In Capital Historical Data

The historical data trend for Hainan Shuangcheng Pharmaceuticals Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hainan Shuangcheng Pharmaceuticals Co Additional Paid-In Capital Chart

Hainan Shuangcheng Pharmaceuticals Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 286.53 286.53 292.90 307.86 319.36

Hainan Shuangcheng Pharmaceuticals Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 317.08 - 319.36 -

Hainan Shuangcheng Pharmaceuticals Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Hainan Shuangcheng Pharmaceuticals Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Hainan Shuangcheng Pharmaceuticals Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Hainan Shuangcheng Pharmaceuticals Co (SZSE:002693) Business Description

Traded in Other Exchanges
N/A
Address
16 Xingguo Road, Xiuying District, Haikou, CHN, 570311
Hainan Shuangcheng Pharmaceuticals Co Ltd is engaged in the research, development, and sales of synthesized peptide drugs.
Executives
Yuan Jian Lin Executives
Zhang Wei Executives
Yu Xiao Feng Directors, executives
Wang Xu Guang Executives
Directors, executives
Wang Cheng Dong Directors, executives
Executives
Hu Yi Securities Affairs Representative

Hainan Shuangcheng Pharmaceuticals Co (SZSE:002693) Headlines

No Headlines